Freeline Therapeutics Holdings plc Analysis
| Analyst Ratings |
|
Average Target Price
|
5.00
|
|
Average Rating
|
4.83
|
|
# Strong Buys
|
5
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.20
|
0.00
|
0.20
|
100.00%
|
|
2022-12-31
|
-0.29
|
0.00
|
0.29
|
100.00%
|
|
2022-09-30
|
-0.44
|
-0.20
|
0.24
|
54.55%
|
|
2022-06-30
|
-0.51
|
-0.32
|
0.19
|
37.25%
|
|
2022-03-31
|
-0.60
|
-0.63
|
-0.03
|
-5.00%
|
|
2021-12-31
|
-0.68
|
-0.96
|
-0.28
|
-41.18%
|
|
2021-09-30
|
-1.01
|
-0.86
|
0.15
|
14.85%
|
|
2021-06-30
|
-0.97
|
-1.12
|
-0.15
|
-15.46%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.15
|
|
2021-12-31
|
-3.92
|
|
2020-12-31
|
-2.56
|